AD-102(Addpharma)

N/A

Report date: 2025/01/08 09:53:43

NME

Base Information

Drug NameAD-102(Addpharma)

Drug Alias NameAD-102(Yuhan)AD102(Yuhan)AD-102AD-102(Addpharma)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsOsteoporosis, Postmenopausal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAddpharma Inc

China Registration ClassN/A

Active CompaniesAddpharma Inc

Inactive CompaniesN/A

Active IndicationsOsteoporosis, Postmenopausal

Inactive IndicationsN/A

ATC CodeN/A